Elevance Health (ELV) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $89.95B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Healthcare Plans |
| Country | US | CEO | Gail Koziara Boudreaux |
| IPO Date | 2001-10-30 | CAGR | 11.3% |
| Employees | 96,615 | Website | www.elevancehealth.com |
| Div. Yield | 1.9% | Payout Ratio | 30% |
| Buy Back Yield | 3.47% | Total Yield | 5.37% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $109.71B | P/E | 14.11 | Forward P/E | 14.01 | PEG | -1.4 |
| P/S | 0.38 | P/B | 1.74 | P/CF | 10.5 | P/FCF | 12.43 |
| Sales | $201.11B | Sales 1Y | 6.27% | Sales 3Y | 21.36% | Sales 5Y | 55.64% |
| EPS | $29.39 | EPS 1Y | -4.26% | EPS 3Y | -14.45% | EPS 5Y | 32.2% |
| Sales QoQ | 0.58% | EPS QoQ | -16.12% | Sales QoQ Avg | 0.36% | EPS QoQ Avg | 30.78% |
| Gross Margin | 38.95% | Operating Margin | 3.51% | Profit Margin | 2.47% | ROCE | 8.59% |
| ROA | 4% | ROE | 11% | Altman Z Score | 2.64 | Piotroski Score | 8 |
| Current Ratio | 1.52 | Quick Ratio | 1.52 | Cash Ratio | 0.23 | Op. CF Ratio | 0.04 |
| Debt/Equity | 0.69 | Debt/Assets | 0.25 | Lt Debt/Equity | 0.68 | Lt Debt/Cap. | 0.41 |
| Intrst Cov. | 6.25 | Inventory Turnover | — | Asset Turnover | 1.59 | Receivables Turnover | 8.6 |
| Enterprise Value | $109.71B | P/E Ratio | 14.11 |
| Forward P/E | 14.01 | PEG Ratio | -1.4 |
| P/S Ratio | 0.38 | P/B Ratio | 1.74 |
| P/CF Ratio | 10.5 | P/FCF Ratio | 12.43 |
| EPS | $29.39 | EPS Growth 1Y | -4.26% |
| EPS Growth 3Y | -14.45% | EPS Growth 5Y | 32.2% |
| Revenue Growth 1Y | 6.27% | Gross Margin | 0.39% |
| Operating Margin | 0.04% | Profit Margin | 0.02% |
| ROE | 0.11% | ROA | 0.04% |
| ROCE | 0.09% | Current Ratio | 1.52 |
| Quick Ratio | 1.52 | Cash Ratio | 0.23 |
| Debt/Equity | 0.69 | Interest Coverage | 6.25 |
| Altman Z Score | 2.64 | Piotroski Score | 8 |
Elevance Health (ELV) valuation & financials
Elevance Health (ELV) has a market capitalization of $89.95B and trades at a price-to-earnings ratio of 14.1. It operates in the Healthcare sector (Medical - Healthcare Plans).
Elevance Health's revenue grew +6.3% over the last year.
Elevance Health's next earnings report is scheduled for October 21, 2026 before market open; analysts estimate EPS of $4.66. Check the earnings calendar to see all companies reporting this week.
Elevance Health (ELV) — frequently asked questions
When does Elevance Health (ELV) report earnings next?
Elevance Health is expected to report earnings on October 21, 2026 before market open. Analysts estimate EPS of $4.66.
What is Elevance Health's market cap?
Elevance Health (ELV) has a market capitalization of $89.95B.
What is ELV's P/E ratio?
Elevance Health trades at a price-to-earnings ratio of 14.1, with trailing twelve-month EPS of $29.39.
How fast is Elevance Health growing?
Elevance Health's revenue grew +6.3% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)